Contributor disclosures are reviewed for conflicts of interest by the editorial group. When found, these are addressed by vetting through a multi-level review process, and through requirements for references to be provided to support the content. Appropriately referenced content is required of all authors and must conform to UpToDate standards of evidence.
INTRODUCTION — The pericardium is a fibroelastic sac made up of visceral and parietal layers separated by a (potential) space, the pericardial cavity. In healthy individuals, the pericardial cavity contains 15 to 50 mL of an ultrafiltrate of plasma.
Diseases of the pericardium present clinically in one of several ways :
●Acute and recurrent pericarditis
●Pericardial effusion without major hemodynamic compromise
Acute pericarditis refers to inflammation of the pericardial sac. The term myopericarditis, or perimyocarditis, is used for cases of acute pericarditis that also demonstrate myocardial inflammation; myopericarditis is used for cases with prevalent pericarditis and normal ventricular function, perimyocarditis is used for cases with prevalent myocarditis and if ventricular function is reduced (new wall motion abnormalities or reduced ventricular function). The clinical presentation and diagnostic evaluation for acute pericarditis will be reviewed here. The etiology of pericarditis, treatment and prognosis of acute pericarditis, and other pericardial disease processes are discussed separately. (See "Etiology of pericardial disease" and "Acute pericarditis: Treatment and prognosis" and "Recurrent pericarditis" and "Myopericarditis" and "Cardiac tamponade" and "Constrictive pericarditis" and "Diagnosis and treatment of pericardial effusion".)
EPIDEMIOLOGY — Acute pericarditis is the most common disorder involving the pericardium. Epidemiologic studies are largely lacking, and the exact incidence and prevalence of acute pericarditis are unknown. However, acute pericarditis is recorded in about 0.1 to 0.2 percent of hospitalized patients and 5 percent of patients admitted to the Emergency Department for non-ischemic chest pain [2,3].
●In an observational study from an urban area in Northern Italy the incidence of acute pericarditis was 27.7 cases per 100,000 persons per year .
●In an observational study from Finland that included 670,409 cardiovascular admissions to 29 hospitals across the country over a 9.5-year period, the standardized incidence rate for pericarditis requiring hospitalization was 3.3 cases per 100,000 person-years .
Acute pericarditis is a common disorder in several clinical settings, where it may be either the first manifestation of an underlying systemic disease or represent an isolated process (table 1). In developed countries, most cases of acute pericarditis are considered of possible or confirmed viral origin, although the exact etiology of most cases remains undetermined following a traditional diagnostic approach [5-7].
Prior to the widespread availability of antiretroviral therapy to treat infection with the human immunodeficiency virus (HIV), pericardial disease was the most frequent cardiovascular manifestation of the acquired immune deficiency syndrome (AIDS) [8,9]. However, in developed countries with access to HIV therapy, patients with HIV infection who develop acute pericarditis have an etiologic spectrum very similar to non-HIV infected patients. On the contrary, HIV infection and tuberculosis persist as major causes of acute pericarditis in developing countries. (See "Cardiac and vascular disease in HIV-infected patients", section on 'Pericardial disease'.)
CLINICAL FEATURES — Acute pericarditis can present with a variety of nonspecific signs and symptoms, depending on the underlying etiology. The major clinical manifestations of acute pericarditis include [5,10]:
●Chest pain – Typically sharp and pleuritic, improved by sitting up and leaning forward
●Pericardial friction rub – A superficial scratchy or squeaking sound best heard with the diaphragm of the stethoscope over the left sternal border
●Electrocardiogram (ECG) changes – New widespread ST elevation or PR depression
Patients with an infectious etiology may present with signs and symptoms of systemic infection such as fever and leukocytosis. Viral etiologies in particular may be preceded by “flu-like” respiratory or gastrointestinal symptoms. Patients with a known autoimmune disorder or malignancy may present with signs or symptoms specific to their underlying disorder.
Determination of risk and need for hospitalization — High-risk patients with acute pericarditis should be admitted to the hospital in order to initiate appropriate therapy and expedite a thorough initial evaluation. Patients with high-risk features are at increased risk of short-term complications and have a higher likelihood of a specific disease etiology [11,12]. Conversely, patients with uncomplicated (ie, low-risk) acute pericarditis can usually be evaluated and sent home, with outpatient follow-up to assess the efficacy of treatment and complete the diagnostic evaluation [6,11-13].
Features of acute pericarditis associated with a higher risk include [11,12]:
●Fever (>38ºC [100.4ºF])
●Subacute course (without acute onset of chest pain)
●Evidence suggesting cardiac tamponade (eg, hemodynamic compromise) (see "Cardiac tamponade")
●A large pericardial effusion (ie, an end-diastolic echo-free space of more than 20 mm)
●Immunosuppression and immunodepressed patients
●A history of therapy with vitamin K antagonists (eg, warfarin) or novel oral anticoagulants
●Failure to show clinical improvement following seven days of appropriately dosed NSAID and colchicine therapy
●Elevated cardiac troponin, which suggests myopericarditis/perimyocarditis
Historically, many clinicians admitted all new cases of acute pericarditis to the hospital, but this is not necessary. In one report of 300 consecutive patients with acute pericarditis, 15 percent were deemed high risk at presentation and were hospitalized . In the remaining 85 percent of patients who were low risk, outpatient aspirin therapy was effective in 87 percent, and none of these patients had a serious complication (eg, cardiac tamponade) at a mean follow-up of 38 months.
Although chronic use of glucocorticoids should not be considered as a risk factor in a general population of patients with acute pericarditis, they were associated with an increased rate of complications in idiopathic or viral pericarditis . Glucocorticoid therapy given for the index attack may increase the chance of recurrence, possibly because of its deleterious effect on viral replication and clearance. (See "Recurrent pericarditis", section on 'Predictors of recurrence'.)
Chest pain — The vast majority of patients with acute pericarditis present with chest pain (>95 percent of cases) . The chest pain of pericarditis must always be distinguished from other common and/or life-threatening causes of chest pain (table 2) such as myocardial ischemia, pulmonary embolism, aortic dissection, gastroesophageal reflux disease, and musculoskeletal pain. (See "Evaluation of the adult with chest pain in the emergency department" and "Outpatient evaluation of the adult with chest pain".)
Chest pain that results from acute pericarditis is typically fairly sudden in onset and occurs over the anterior chest. Unlike pain from myocardial ischemia, chest pain due to pericarditis is most often sharp and pleuritic in nature, with exacerbation by inspiration or coughing. One of the most distinctive features is the tendency for a decrease in intensity when the patient sits up and leans forward [5,14]. This position (seated, leaning forward) tends to reduce pressure on the parietal pericardium, particularly with inspiration, and may also allow for splinting of the diaphragm . Radiation of chest pain to the trapezius ridge has also been considered to be fairly specific for pericarditis. However, dull, oppressive pain may occur; in such cases, it is difficult to distinguish pericarditis from other causes of chest pain [5,14].
Chest pain is likely to be present in cases of acute pericarditis caused by infection, but may be minimal or absent in patients with uremic pericarditis or pericarditis associated with a rheumatologic disorder (although in some patients pleuritic chest pain and pericarditis can be the initial presentation of systemic lupus erythematosus).
Pericardial friction rub — The presence of a pericardial friction rub on physical examination is highly specific for acute pericarditis (movie 1). Classically, pericardial friction rubs are triphasic with a superficial scratchy or squeaking quality. Pericardial friction rubs are often intermittent, with an intensity that tends to wax and wane, and are best heard using the diaphragm of the stethoscope.
Pericardial friction rubs, which occur during maximal movement of the heart within its pericardial sac, are said to be generated by friction between the two inflamed layers of the pericardium. However, this commonly offered explanation for its mechanism may be an oversimplification as patients with a pericardial effusion may also have an audible friction rub.
The classic pericardial friction rub consists of three phases, corresponding to movement of the heart during atrial systole, ventricular systole, and the rapid filling phase of early ventricular diastole. Patients in atrial fibrillation lack atrial systole, and therefore will have a two phase rub. Additionally, for uncertain reasons, some rubs are present only during one (one component) or two phases (two components) of the cardiac cycle . In a review of auscultation and phonocardiography in 100 patients with a pericardial rub, the rub was triphasic in 56 percent of patients in sinus rhythm, biphasic in 33 percent, and monophasic in 15 percent .
Pericardial rubs may be localized or widespread, but are usually loudest over the left sternal border . The intensity of the rub frequently increases after application of firm pressure with the diaphragm, during suspended respiration, and with the patient leaning forward or resting on elbows and knees (picture 1). This last maneuver is designed to increase contact between visceral and parietal pericardium, but is seldom used in practice since it is cumbersome for the patient.
Friction rubs tend to vary in intensity and can come and go over a period of hours; therefore, the sensitivity for detection of a rub is variable and depends in large part on the frequency of auscultation . Pericardial rubs may be easier to hear in patients without a pericardial effusion, but this finding is not universal and is not well-documented. In a report of 100 patients with acute pericarditis, a pericardial rub was present in 34 of 40 (85 percent) without an effusion . This prevalence is considerably higher than the 35 percent incidence of friction rubs reported in another series .
Suspension of respiration during auscultation permits distinction of a pericardial friction rub from a pleuropericardial or pleural rub. A pleuropericardial rub results from the friction between the inflamed pleura and the parietal pericardium, while a pleural rub is the result of friction between the inflamed visceral and parietal pleura. As such, pleuropericardial and pleural rubs can be heard only during the inspiratory phase of respiration. (See "Auscultation of heart sounds", section on 'Pericardial friction rub and other adventitious sounds'.)
Electrocardiogram — The electrocardiogram (ECG) in acute pericarditis can evolve through as many as four stages of changes, and the temporal evolution of ECG changes can be highly variable [5,14]. The four stages of typical ECG changes in patients with acute pericarditis include:
●Stage 1, seen in the first hours to days, is characterized by diffuse ST elevation (typically concave up) with reciprocal ST depression in leads aVR and V1 (waveform 1). There is also frequently an atrial current of injury, reflected by elevation of the PR segment in lead aVR and depression of the PR segment in other limb leads and in the left chest leads, primarily V5 and V6. Thus, the PR and ST segments typically change in opposite directions. PR segment deviation, which is highly specific though less sensitive, is frequently overlooked.
The TP segment is recommended as the baseline for comparison when measuring both PR and ST segment changes in acute pericarditis .
●Stage 2, typically seen in the first week, is characterized by normalization of the ST and PR segments.
●Stage 3 is characterized by the development of diffuse T-wave inversions, generally after the ST segments have become isoelectric. Its duration is not well-documented and likely highly variable.
●Stage 4 is represented by normalization of the ECG.
However, pericarditis does not always result in these typical ECG changes. Many patients normalize without going past stage 1. Moreover, atypical ECG changes are seen in up to 40 percent of patients with acute pericarditis . Additionally, localized ST-elevation and T-wave inversion occur before ST-segment normalization in a minority of patients with acute pericarditis without myocardial involvement. These changes can simulate ECG changes seen in patients with an acute coronary syndrome. (See 'ECG differentiation from acute myocardial infarction' below and "ECG tutorial: Myocardial ischemia and infarction" and "ECG tutorial: ST and T wave changes".)
Changes in the ECG in patients with acute pericarditis signify inflammation of the epicardium, since the parietal pericardium itself is electrically inert. However, some causes of pericarditis do not result in significant inflammation of the epicardium and, as such, may not alter the ECG. An illustration of this is uremic pericarditis, in which there is prominent fibrin deposition but little or no epicardial inflammation. As a result, the ECG often shows none of the changes associated with pericarditis . (See "Pericarditis in renal failure".)
The temporal evolution of ECG changes with acute pericarditis is highly variable from one patient to another . Treatment can accelerate or alter ECG progression. The duration of the ECG changes in pericarditis also depends upon its cause and the extent of the associated myocardial damage .
Sustained arrhythmias are uncommon in acute pericarditis, except in the post-thoracotomy setting. This was illustrated in a review of 100 consecutive patients in which only seven arrhythmias were identified; all were atrial and all occurred in patients with underlying heart disease . In a separate report comparing patients with myopericarditis and simple acute pericarditis, cardiac arrhythmias were also more commonly present in patients with myopericarditis (odds ratio 17.6, 95% confidence interval 5.7 to 54.1) . Thus, the presence of atrial or ventricular arrhythmias is suggestive of concomitant myocarditis or an unrelated cardiac disease.
ECG differentiation from acute myocardial infarction — While both acute pericarditis and acute myocardial infarction can present with chest pain and elevations in cardiac biomarkers, the electrocardiographic changes in acute pericarditis differ from those in acute ST elevation MI (STEMI) in several ways . These distinctions assume that the pericarditis does not occur during or soon after an acute MI. (See "Electrocardiogram in the diagnosis of myocardial ischemia and infarction" and "Pericardial complications of myocardial infarction" and "ECG tutorial: ST and T wave changes" and "ECG tutorial: Myocardial ischemia and infarction".)
●Morphology – The ST segment elevation in acute pericarditis begins at the J point, which represents the junction between the end of the QRS complex (termination of depolarization) and the beginning of the ST segment (onset of ventricular repolarization), rarely exceeds 5 mm, and usually retains its normal concavity (waveform 1). Although similar patterns can occur with STEMI (where ST segment elevation also begins at the J point), the typical finding in a STEMI patient is convex (dome-shaped) ST elevation (a pattern not characteristic of acute pericarditis) that may be more than 5 mm in height (waveform 2).
●Distribution – ST segment elevations in STEMI are characteristically limited to anatomical groupings of leads that correspond to the localized vascular area of the infarct (anteroseptal and anterior leads V1 to V4; lateral leads I, aVL, V5, V6; inferior leads II, III, aVF) (waveform 2). The pericardium envelops the heart, therefore the ST changes are more generalized and typically are present in most leads (waveform 1).
●Reciprocal changes – Acute STEMI is often associated with reciprocal ST segment changes, which are not seen with pericarditis except in leads aVR and V1.
●Concurrent ST and T wave changes – ST segment elevation and T wave inversions do not generally occur simultaneously in pericarditis, while they commonly coexist in acute STEMI (waveform 2). Furthermore, the evolution of repolarization abnormalities often takes place more slowly and more asynchronously among affected leads in pericarditis than in STEMI.
●PR segment – PR elevation in aVR with PR depression in other leads due to a concomitant atrial current of injury is frequently seen in acute pericarditis but rarely seen in acute STEMI.
●Other – Hyperacute T waves (waveform 3A-B), new pathologic Q waves, and QT prolongation are all rarely seen in patients with acute pericarditis but are more common in acute MI.
ECG differentiation from early repolarization — The early repolarization variant seen on an ECG may be present in as many as 30 percent of young adults and is often confused with acute pericarditis . Early repolarization is characterized by ST elevation of the J point, which represents the junction between the end of the QRS complex (termination of depolarization) and the beginning of the ST segment (onset of ventricular repolarization). As a result, there is elevation of the ST segment itself, which maintains its normal configuration (waveform 4). In early repolarization, ST elevation is most often present in the anterior and lateral chest leads (V3-V6), although other leads can be involved. (See "Early repolarization".)
The following electrocardiographic features can be helpful in distinguishing acute pericarditis from early repolarization:
●ST elevations occur in both the limb and precordial leads in most cases of acute pericarditis (47 of 48 in one study), whereas about one-half of subjects with early repolarization have no ST deviations in the limb leads .
●PR deviation and evolution of the ST and T changes strongly favor pericarditis, as neither is seen in early repolarization.
●If the ratio of ST elevation to T wave amplitude in lead V6 exceeds 0.24, acute pericarditis is present (positive and negative predictive values are both 100 percent) .
Our approach to diagnostic testing — For a patient who presents with suspected acute pericarditis, we recommend the following evaluation:
●Initial history and physical examination – This evaluation should consider disorders that are known to involve the pericardium, such as prior malignancy, autoimmune disorders, uremia, recent myocardial infarction, and prior cardiac surgery. The examination should pay particular attention to auscultation for a pericardial friction rub and the signs associated with cardiac tamponade.
●Initial testing in all suspected cases:
•An electrocardiogram. (See 'Electrocardiogram' above.)
•Chest radiography. (See 'Chest x-ray' below.)
•Echocardiography, with urgent echocardiography if cardiac tamponade is suspected. Even a small effusion can be helpful in confirming the diagnosis of pericarditis, although the absence of an effusion does not exclude the diagnosis . In addition, echocardiography can be particularly helpful if purulent pericarditis is suspected, if there is concern about myocarditis, or if there is radiographic evidence of cardiomegaly, particularly if this is a new finding. (See 'Echocardiogram' below.)
The 2003 American College of Cardiology/American Heart Association/American Society of Echocardiography (ACC/AHA/ASE) guidelines for the clinical application of echocardiography stated that evidence and/or general agreement supported the use of echocardiography for the evaluation of all patients with suspected pericardial disease . Similarly, a 2013 expert consensus statement from the ASE recommends echocardiography for all patients with acute pericarditis .
●Selected additional testing – Follow up testing should be performed on a case by case basis and may include:
•Blood cultures if fever higher than 38ºC (100.4ºF), signs of sepsis, or a documented, concomitant bacterial infection (eg, pneumonia).
•Viral studies (eg, culture, PCR, viral serology, etc) are not routinely obtained, since the yield is low and management is not altered for the vast majority of patients .
•Antinuclear antibody (ANA) titer in selected cases (eg, young women, especially those in whom the history suggests a rheumatologic disorder). Rarely, acute pericarditis is the initial presentation of systemic lupus erythematosus (SLE). It is important to recognize that a positive ANA is a non-specific test. A rheumatology consult should be sought in patients with pericarditis in whom a diagnosis of SLE is being entertained. (See "Non-coronary cardiac manifestations of systemic lupus erythematosus in adults".)
•Tuberculin skin test or an interferon-gamma release assay (eg, QuantiFERON TB assay) if not recently performed. The interferon-gamma release assay is most helpful in immunocompromised or HIV positive patients and in regions where tuberculosis is endemic.
•Multimodality imaging is an integral part of modern management for pericarditis and pericardial diseases. Among multimodality imaging tests, echocardiography is recommended for all patients, followed by cardiac magnetic resonance (CMR) with administration of gadolinium or computed tomography (CT) imaging for selected patients (eg, non-diagnostic echocardiography, concerns about constrictive pericarditis, complicated course, suspicion of specific etiology, etc) [26,29].
•Pericardiocentesis should be performed for therapeutic purposes in patients with cardiac tamponade, and should be considered for diagnostic purposes in patients suspected of having a malignant or bacterial etiology, or in patients with a symptomatic effusion refractory to medical therapy.
Echocardiogram — Echocardiography is often normal in patients with the clinical syndrome of acute pericarditis unless there is an associated pericardial effusion. While the finding of a pericardial effusion in a patient with known or suspected pericarditis supports the diagnosis, the absence of a pericardial effusion or other echocardiographic abnormalities does not exclude it.
Large and/or hemodynamically significant pericardial effusions are rare as the initial presentation of acute pericarditis. In one series of 300 consecutive patients with acute pericarditis, pericardial effusion was present in 180 patients (60 percent). In most cases the effusion was small or moderate in size (79 and 10 percent, respectively) without hemodynamic consequences. Cardiac tamponade was present in only 5 percent of patients . (See "Echocardiographic evaluation of the pericardium" and "Diagnosis and treatment of pericardial effusion".)
Chest x-ray — Chest radiography is typically normal in patients with acute pericarditis. Although patients with a substantial pericardial effusion may exhibit an enlarged cardiac silhouette with clear lung fields (image 1), this finding is uncommon in acute pericarditis since at least 200 mL of pericardial fluid must accumulate before the cardiac silhouette enlarges [2,5]. However, acute pericarditis should be considered in the evaluation of a patient with new and otherwise unexplained cardiomegaly.
Cardiac biomarkers — Acute pericarditis may be associated with increases in serum biomarkers of myocardial injury such as cardiac troponin I or T. In one series of 118 consecutive cases with idiopathic acute pericarditis an elevated level of cardiac troponin I was detected in 38 patients (32 percent) . Such patients should be considered to have myopericarditis. (See "Myopericarditis", section on 'Laboratory studies'.)
Signs of inflammation — Since pericarditis is an inflammatory disease, laboratory signs of inflammation are common in patients with acute pericarditis. These include elevations in the white blood cell count, erythrocyte sedimentation rate, and serum C-reactive protein concentration. While elevation in these markers supports the diagnosis, they are neither sensitive nor specific for acute pericarditis. Additionally, in the hyperacute phase of pericarditis, these markers may remain normal and increased levels may be found only on follow-up.
CMR and/or CT — Computed tomography (CT) may be useful to confirm the diagnosis and especially evaluate concomitant pleuropulmonary diseases and lymphadenopathies, thus suggesting a possible etiology of pericarditis (ie, TB, lung cancer) . Noncalcified pericardial thickening with pericardial effusion is suggestive of acute pericarditis. Moreover, with the administration of iodinated contrast media, enhancement of the thickened visceral and parietal surfaces of the pericardial sac confirms the presence of active inflammation. Computed tomographic attenuation values can help in the differentiation of exudative fluid (20 to 60 Hounsfield units), as found with purulent pericarditis, and simple transudative fluid (<10 Hounsfield units).
Cardiac magnetic resonance (CMR) imaging provides useful assessment of pericardial inflammation since the inflamed pericardium is bright and thickened on T2-weighted imaging (edema) and enhanced after contrast injection (late gadolinium enhancement). Concomitant myocarditis may also be depicted simultaneously during CMR. Evidence of pericardial inflammation by CT/CMR is a supportive finding for the diagnosis of pericarditis in doubtful cases (eg, atypical presentation, chest pain without C-reactive protein elevation, or other objective evidence of disease).
Pericardiocentesis and pericardial biopsy — Studies in patients with acute pericarditis have reported a low yield for diagnostic pericardiocentesis and pericardial biopsy; however, some authors have advocated for a more extensive use of these techniques for diagnostic purposes. The majority of patients with uncomplicated acute pericarditis do not require invasive pericardial procedures. However, some high-risk patients may require pericardiocentesis for both therapeutic and diagnostic purposes (table 3). In addition, while pericardial biopsy is not required to make the diagnosis of acute pericarditis, it may rarely be necessary in an attempt to diagnose a specific etiology. (See "Acute pericarditis: Treatment and prognosis", section on 'Adjunctive therapies'.)
●Pericardiocentesis — In patients with a pericardial effusion, pericardiocentesis or surgical drainage can serve both diagnostic and therapeutic purposes. Among patients with acute pericarditis, decisions regarding drainage of the pericardial space are based upon the presence of an associated effusion, its echocardiographic characteristics (eg, size and composition), and clinical significance (eg, causing hemodynamic compromise).
•Patients with symptomatic effusions and evidence of cardiac tamponade should undergo prompt pericardial drainage. (See "Cardiac tamponade".)
•When a significant pericardial effusion is present, a diagnostic pericardiocentesis is indicated if a specific etiology is highly suspected, and diagnosis cannot be reached by other means. The investigation is especially indicated when a neoplastic or bacterial etiology is suspected and a definite diagnosis can only be made by identification of the etiologic agent in the pericardial fluid. Fluid samples should be sent for cytology, tumor markers, Gram stain, bacterial cultures, and, if tuberculosis is suspected, polymerase chain reaction testing for tuberculosis. (See "Diagnosis and treatment of pericardial effusion" and "Pericardial disease associated with malignancy".)
•Pericardiocentesis may also be performed for diagnostic and/or therapeutic purposes for large effusions refractory to medical treatment .
•Effusions that are small to moderate in size and do not cause hemodynamic compromise (ie, cardiac tamponade) generally do not require drainage, unless a sample of the effusion is necessary for diagnostic purposes. Moreover, pericardiocentesis performed percutaneously has a significantly higher complication rate if the effusion is not large.
A detailed discussion regarding the performance of pericardiocentesis and the treatment of pericardial effusions is presented separately. (See "Diagnosis and treatment of pericardial effusion".)
●Pericardial biopsy — Pericardial biopsy is generally performed as a part of a therapeutic procedure (surgical drainage) in patients with recurrent pericardial effusions and cardiac tamponade after prior pericardiocentesis (therapeutic biopsy), and as a diagnostic procedure in patients with an illness lasting more than three weeks despite treatment without a definite diagnosis. Technical advances in instrumentation with introduction of pericardioscopy, and in contemporary virology and molecular biology have improved the diagnostic value of epicardial/pericardial biopsy. The diagnostic yield of pericardial biopsy is typically higher in patients with pericardial effusion with or without pericarditis than in those who present with apparent acute pericarditis without effusion. Polymerase chain reaction techniques may represent a useful adjunct to conventional laboratory studies in the investigation of pericardial samples, allowing the rapid identification of microorganisms otherwise not easily found [30,31]. Tissue samples should be sent for cytology, tumor markers, gram stain, bacterial cultures, and, if tuberculosis is suspected, polymerase chain reaction testing. (See "Diagnosis and treatment of pericardial effusion", section on 'Pericardial fluid analysis and biopsy'.)
Establishing a definite etiology — Because of the relatively benign course associated with the common causes of pericarditis, along with the relatively low yield of much of the diagnostic testing, it is not necessary to establish a definite etiology in all patients with acute pericarditis. Initial efforts should focus upon excluding a significant pericardial effusion or cardiac tamponade and the identification of patients in whom a more comprehensive evaluation should be performed to exclude causes that require specific therapy (eg, malignancy, tuberculosis or purulent pericarditis) (table 1) . In addition, among patients at high risk of coronary disease, myocardial ischemia must be ruled out by appropriate studies.
The yield of the standard diagnostic evaluation to determine the etiology of acute pericarditis is relatively low. This was illustrated in three series that included a total of 784 unselected patients who underwent an extensive evaluation [12,17,28]. A specific diagnosis was established in only 130 patients (17 percent) (table 4). The most commonly confirmed diagnoses were:
●Neoplasia – 5 percent
●Tuberculosis – 4 percent
●Autoimmune etiologies – 5 percent
●Purulent pericarditis – 1 percent
In developed countries, unless there is an apparent medical or surgical condition known to be associated with pericarditis, most cases of acute pericarditis in immunocompetent patients are due to viral infection or are idiopathic (table 1 and table 4) [6,11-13,32-34]. Acute viral or idiopathic pericarditis typically follows a brief and benign course after empiric treatment with antiinflammatory drugs. (See "Acute pericarditis: Treatment and prognosis".)
●Typical chest pain (sharp and pleuritic, improved by sitting up and leaning forward)
●Pericardial friction rub (a superficial scratchy or squeaking sound best heard with the diaphragm of the stethoscope over the left sternal border) (movie 1)
●Suggestive changes on the electrocardiogram (typically widespread ST segment elevation) (waveform 1)
●New or worsening pericardial effusion
These diagnostic criteria are consistent with the 2015 European Society of Cardiology guidelines on pericardial diseases . In atypical presentations, additional supporting findings include the evidence of systemic inflammation (eg, elevation of C-reactive protein) or pericardial inflammation on an imaging technique such as pericardial contrast-enhancement on CT or pericardial edema and late gadolinium enhancement on cardiac magnetic resonance (CMR) [10,35]. (See 'CMR and/or CT' above.)
The diagnosis of acute pericarditis is usually suspected based on a history of characteristic pleuritic chest pain, and confirmed if a pericardial friction rub is present. Pericarditis should also be suspected in a patient with persistent fever and either a pericardial effusion or new unexplained cardiomegaly . Additional testing, which typically includes blood work, chest radiography, electrocardiography, and echocardiography, can support the diagnosis but is frequently normal or unrevealing. The electrocardiogram is usually the most helpful test in the evaluation of patients with suspected acute pericarditis. Echocardiography is often normal, but can be an essential part of the evaluation if there is evidence of an associated pericardial effusion and/or signs of cardiac tamponade.
Acute pericarditis refers to inflammation of the pericardial sac. The term myopericarditis, or perimyocarditis, is used for cases of acute pericarditis that also demonstrate features consistent with myocardial inflammation. Because the same viruses that are responsible for acute pericarditis can also cause myocarditis, it is not uncommon to find some degree of myocardial involvement in patients with acute pericarditis. The terms "myopericarditis" and "perimyocarditis" are sometimes used interchangeably or they can be used to indicate the dominant site of involvement. Cases that involve the myocardium in which pericarditis is predominant are reported as myopericarditis; alternatively, the term perimyocarditis is sometimes used when myocardial involvement is most prominent. However, in clinical practice, myopericarditis is more common and this term is often used in both senses. (See "Myopericarditis".)
INFORMATION FOR PATIENTS — UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
●Basics topics (see "Patient education: Pericarditis in adults (The Basics)")
●Beyond the Basics topic (see "Patient education: Pericarditis (Beyond the Basics)")
SUMMARY AND RECOMMENDATIONS
●Acute pericarditis (inflammation of the pericardial sac) is the most common disorder of the pericardium and is seen in about 0.1 percent of hospitalized patients and 5 percent of patients admitted to the Emergency Department for non-ischemic chest pain. (See 'Epidemiology' above.)
●Idiopathic cases, most of which are probably viral in etiology, are the most common causes of acute pericarditis. Other etiologies of acute pericarditis include bacterial infections, malignancy, and autoimmune disorders (table 4). The distribution of etiologies varies with geography and type of clinical setting (community hospital versus tertiary referral center). (See 'Epidemiology' above.)
●Acute pericarditis can present with a variety of nonspecific signs and symptoms, depending on the underlying etiology. The major clinical manifestations of acute pericarditis include pleuritic chest pain, pericardial friction rub, and ECG changes, with or without a pericardial effusion. Pericarditis should also be suspected in a patient with persistent fever and pericardial effusion or new unexplained cardiomegaly. (See 'Clinical features' above.)
●High-risk patients with acute pericarditis should be admitted in order to initiate appropriate therapy and to expedite a thorough initial evaluation. Patients with high-risk features are at increased risk of short-term complications and have a higher likelihood of a specific disease. Conversely, patients with uncomplicated (ie, low-risk) acute pericarditis can usually be evaluated and sent home, with outpatient follow-up. (See 'Determination of risk and need for hospitalization' above.)
●For all patients with suspected acute pericarditis, the initial evaluation includes a comprehensive history and physical examination, selective blood work (assessing for markers of inflammation or myocardial damage), chest radiography, electrocardiography, and echocardiography. Follow-up testing should be performed on a case by case basis and may include blood cultures, additional bloodwork (eg, ANA titer, HIV serology, etc), and additional cardiac imaging. (See 'Our approach to diagnostic testing' above.)
•Typical chest pain (sharp and pleuritic, improved by sitting up and leaning forward). (See 'Chest pain' above.)
•New or worsening pericardial effusion. (See 'Echocardiogram' above.)
●Because of the relatively benign course associated with the common causes of pericarditis, along with the relatively low yield of much of the diagnostic testing, it is not necessary to establish a definite etiology in all patients with acute pericarditis. Initial efforts should focus upon excluding a significant pericardial effusion or cardiac tamponade and the identification of patients in whom a more comprehensive evaluation should be performed to exclude causes that require specific therapy (eg, malignancy, tuberculosis or purulent pericarditis) (table 1). (See 'Establishing a definite etiology' above.)
- Imazio M. Contemporary management of pericardial diseases. Curr Opin Cardiol 2012; 27:308.
- Spodick DH. Acute cardiac tamponade. N Engl J Med 2003; 349:684.
- Kytö V, Sipilä J, Rautava P. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation 2014; 130:1601.
- Imazio M, Cecchi E, Demichelis B, et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart 2008; 94:498.
- Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet 2004; 363:717.
- Lange RA, Hillis LD. Clinical practice. Acute pericarditis. N Engl J Med 2004; 351:2195.
- Little WC, Freeman GL. Pericardial disease. Circulation 2006; 113:1622.
- Heidenreich PA, Eisenberg MJ, Kee LL, et al. Pericardial effusion in AIDS. Incidence and survival. Circulation 1995; 92:3229.
- Chen Y, Brennessel D, Walters J, et al. Human immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature. Am Heart J 1999; 137:516.
- Imazio M, Gaita F, LeWinter M. Evaluation and Treatment of Pericarditis: A Systematic Review. JAMA 2015; 314:1498.
- Imazio M, Demichelis B, Parrini I, et al. Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J Am Coll Cardiol 2004; 43:1042.
- Imazio M, Cecchi E, Demichelis B, et al. Indicators of poor prognosis of acute pericarditis. Circulation 2007; 115:2739.
- Imazio M, Trinchero R. Clinical management of acute pericardial disease: a review of results and outcomes. Ital Heart J 2004; 5:803.
- Spodick DH. Acute pericarditis: current concepts and practice. JAMA 2003; 289:1150.
- Spodick DH. Acute, clinically noneffusive ("dry") pericarditis. In: Spodick DH: The Pericardium: A Comprehensive Textbook, Marcel Dekker, New York 1997. p.94-113.
- Spodick DH. Pericardial rub. Prospective, Multiple observer investigation of pericardial friction in 100 patients. Am J Cardiol 1975; 35:357.
- Zayas R, Anguita M, Torres F, et al. Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis. Am J Cardiol 1995; 75:378.
- Spodick, DH. The Pericardium: A Comprehensive Textbook, Marcel Dekker, New York 1997. p.46-64.
- Rutsky, EA, Rostand, SG . Pericarditis in end-stage renal disease: Clinical characteristics and management. Semin Dial 1989; 2:25.
- Chou TC. Electrocardiography in clinical practice, WB Saunders Company, Philadelphia 1996.
- Spodick DH. Arrhythmias during acute pericarditis. A prospective study of 100 consecutive cases. JAMA 1976; 235:39.
- Chou TC. Electrocardiography in Clinical Practice: Adults and Pediatrics, 4th ed, WB Saunders, Philadelphia 1996.
- Klatsky AL, Oehm R, Cooper RA, et al. The early repolarization normal variant electrocardiogram: correlates and consequences. Am J Med 2003; 115:171.
- Spodick DH. Differential characteristics of the electrocardiogram in early repolarization and acute pericarditis. N Engl J Med 1976; 295:523.
- Ginzton LE, Laks MM. The differential diagnosis of acute pericarditis from the normal variant: new electrocardiographic criteria. Circulation 1982; 65:1004.
- Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 2013; 26:965.
- Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline for the clinical application of echocardiography www.acc.org/qualityandscience/clinical/statements.htm (Accessed on August 24, 2006).
- Permanyer-Miralda G, Sagristá-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol 1985; 56:623.
- Imazio M, Demichelis B, Cecchi E, et al. Cardiac troponin I in acute pericarditis. J Am Coll Cardiol 2003; 42:2144.
- Imazio M, Spodick DH, Brucato A, et al. Controversial issues in the management of pericardial diseases. Circulation 2010; 121:916.
- Imazio M, Brucato A, Derosa FG, et al. Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med (Hagerstown) 2009; 10:217.
- Maisch B, Ristić AD. The classification of pericardial disease in the age of modern medicine. Curr Cardiol Rep 2002; 4:13.
- Imazio M, Bobbio M, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation 2005; 112:2012.
- Permanyer-Miralda G. Acute pericardial disease: approach to the aetiologic diagnosis. Heart 2004; 90:252.
- Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015; 36:2921.